Financial results for the year ended March 31, 2025 Dividend: 10% (? 1.00 per share) Book closure: August 16, 2025 to August 22, 2025 Appointment of Secretarial Auditor: SPANJ & Associates ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Amal Ltd reported a sharp turnaround in FY25, with consolidated revenue from operations rising ~57% YoY to ₹13,531.72 lakhs and consolidated PAT surging to ₹2,929.21 lakhs from ₹170.46 lakhs a year ago (≈17x growth). On a standalone basis, revenue grew ~56% YoY to ₹4,888.11 lakhs and PAT jumped to ₹687.52 lakhs from ₹242.63 lakhs (≈2.8x). Profit before tax margins expanded meaningfully – consolidated PBT went from ₹277.70 lakhs to ₹3,261.15 lakhs. The Board has recommended a final dividend of 10% (₹1.00 per share), subject to shareholder approval at the AGM on August 29, 2025; book closure is August 16–22, 2025. Q4 standalone and consolidated numbers declined sequentially because the wholly-owned subsidiary, Amal Speciality Chemicals Ltd, underwent its annual planned maintenance shutdown in March 2025. Standalone entity carries no borrowings; on a consolidated basis, long-term debt of ₹1,850 lakhs was fully repaid during the year. Statutory auditor Deloitte Haskins & Sells LLP issued an unmodified opinion on both standalone and consolidated results. SPANJ & Associates was appointed as Secretarial Auditor for three years (FY26–FY28).
Strong top-line and bottom-line expansion, debt reduction, and a resumption of dividends indicate a clear operational turnaround at both the standalone company and its subsidiary, which should be viewed positively by shareholders. Retail investors should note that the company is a small-cap, low-float stock, so the result may not translate into proportionate price action and quarterly trends can be volatile due to the subsidiary's shutdown cycle.